These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9626391)

  • 1. Personality subtypes, coping styles, symptom correlates, and substances of choice among a cohort of substance abusers.
    Quirk SW; McCormick RA
    Assessment; 1998 Jun; 5(2):157-69. PubMed ID: 9626391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of NEO-PI performance to coping styles, patterns of use, and triggers for use among substance abusers.
    McCormick RA; Dowd ET; Quirk S; Zegarra JH
    Addict Behav; 1998; 23(4):497-507. PubMed ID: 9698978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center.
    Lambert MT; Griffith JM; Hendrickse W
    Psychiatr Serv; 1996 Oct; 47(10):1104-7. PubMed ID: 8890339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting relapse to substance abuse as a function of personality dimensions.
    Fisher LA; Elias JW; Ritz K
    Alcohol Clin Exp Res; 1998 Aug; 22(5):1041-7. PubMed ID: 9726270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personality disorder features as predictors of symptoms five years post-treatment.
    Jansson I; Hesse M; Fridell M
    Am J Addict; 2008; 17(3):172-5. PubMed ID: 18463992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motivational subtypes in an inpatient sample of substance abusers.
    Isenhart CE
    Addict Behav; 1994; 19(5):463-75. PubMed ID: 7832005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention in substance abuse treatment. Role of psychiatric symptom severity.
    Ross HE; Cutler M; Sklar SM
    Am J Addict; 1997; 6(4):293-303. PubMed ID: 9398927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric comorbidity in hospitalized adolescent substance abusers.
    Hovens JG; Cantwell DP; Kiriakos R
    J Am Acad Child Adolesc Psychiatry; 1994 May; 33(4):476-83. PubMed ID: 8005900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fitting a two-parameter logistic item response model to clarify the psychometric properties of the Drug Use Screening Inventory for adolescent alcohol and drug abusers.
    Kirisci L; Tarter RE; Hsu TC
    Alcohol Clin Exp Res; 1994 Dec; 18(6):1335-41. PubMed ID: 7695027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coping capacity in female adolescent substance abusers.
    Mezzich AC; Tarter RE; Kirisci L; Hsieh YC; Grimm M
    Addict Behav; 1995; 20(2):181-7. PubMed ID: 7484312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance-use situations and abstinence predictions in substance abusers with and without personality disorders.
    Van Horn DH; Frank AF
    Am J Drug Alcohol Abuse; 1998 Aug; 24(3):395-404. PubMed ID: 9741942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use disorders in a sample of Canadian patients with chronic mental illness.
    Toner BB; Gillies LA; Prendergast P; Cote FH; Browne C
    Hosp Community Psychiatry; 1992 Mar; 43(3):251-4. PubMed ID: 1555819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axis II comorbidity in substance abusers.
    Nace EP; Davis CW; Gaspari JP
    Am J Psychiatry; 1991 Jan; 148(1):118-20. PubMed ID: 1984695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personality characterizations of outpatients with schizophrenia, schizophrenia with substance abuse, and primary substance abuse.
    Reno RM
    J Nerv Ment Dis; 2004 Oct; 192(10):672-81. PubMed ID: 15457110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the SCID in substance abuse patients.
    Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ
    Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personality characteristics of cocaine and alcohol abusers: more alike than different.
    Johnson RS; Tobin JW; Cellucci T
    Addict Behav; 1992; 17(2):159-66. PubMed ID: 1316717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopathological stability of personality disorders in substance abuse patients treated in a therapeutic community.
    Vergara-Moragues E; González-Saiz F; Lozano OM; Verdejo García A
    J Addict Dis; 2013; 32(4):343-53. PubMed ID: 24325768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity issues in using the Millon-II with substance abusers.
    Bishop DR
    Psychol Rep; 1993 Aug; 73(1):27-33. PubMed ID: 8367567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personality disorder and dimension differences between type A and type B substance abusers.
    Ball SA; Kranzler HR; Tennen H; Poling JC; Rounsaville BJ
    J Pers Disord; 1998; 12(1):1-12. PubMed ID: 9573515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.